title: Statistical analysis plan of PROWESS SHOCK study.
authors.forename: B Taylor
authors.initials: BT
authors.lastname: Thompson
authors.forename: V Marco
authors.initials: VM
authors.lastname: Ranieri
authors.forename: Simon
authors.initials: S
authors.lastname: Finfer
authors.forename: Philip S
authors.initials: PS
authors.lastname: Barie
authors.forename: Jean-Francois
authors.initials: JF
authors.lastname: Dhainaut
authors.forename: Ivor S
authors.initials: IS
authors.lastname: Douglas
authors.forename: Bengt
authors.initials: B
authors.lastname: Gårdlund
authors.forename: John C
authors.initials: JC
authors.lastname: Marshall
authors.forename: Andrew
authors.initials: A
authors.lastname: Rhodes
mesh_terms: D026683:Advisory Committees; D000890:Anti-Infective Agents / Q000627:therapeutic use; D035843:Biomedical Research; D003627:Data Interpretation, Statistical; D006801:Humans; D011486:Protein C / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy / Q000401:mortality*
chemical_list: D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated